TLR4 promotes HCC via several mechanisms, including increasing expression of NANOG, Caspase-1, Ephrin-A1, NO, and BCL6 and increasing the number of T regulatory lymphocytes 17, 18, 25. The gene discussed is NANOG; the disease is hepatocellular carcinoma.